CSIMarket Company Name, Ticker, Suppliers, else..
 
Evogene Ltd   (NASDAQ: EVGN)
 

Evogene Ltd's Suppliers Performance

EVGN's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
EVGN Costs vs Sales of Suppliers Growth

• More on EVGN Suppliers






Evogene Ltd's Comment on Supply Chain


The company sources molecules from a supplier in Ukraine, which has faced and may continue to face limitations in molecule access due to the war in Ukraine. This supplier has an alternative production site and is not the sole provider of research molecules. The company is developing seed-trait product candidates internally through its Ag-Seeds division and is working to commercialize castor seeds for industrial applications via its subsidiary, Casterra. The supply chain for castor oil used industrially is evolving and not well established, requiring Casterra to demonstrate the commercial-scale viability of its castor bean seeds as a cost-efficient feedstock. Additionally, Biomica's future prospects rely on a third-party licensee for the development and commercialization of its microbiome-based product candidate, BMC 128.

Evogene Ltd's Comment on Supply Chain


The company sources molecules from a supplier in Ukraine, which has faced and may continue to face limitations in molecule access due to the war in Ukraine. This supplier has an alternative production site and is not the sole provider of research molecules. The company is developing seed-trait product candidates internally through its Ag-Seeds division and is working to commercialize castor seeds for industrial applications via its subsidiary, Casterra. The supply chain for castor oil used industrially is evolving and not well established, requiring Casterra to demonstrate the commercial-scale viability of its castor bean seeds as a cost-efficient feedstock. Additionally, Biomica's future prospects rely on a third-party licensee for the development and commercialization of its microbiome-based product candidate, BMC 128.







EVGN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Evogene Ltd 4.22 3.85 -7.83 31
SUBTOTAL 0.00 0.00 0.00 -


Sources: Evogene Ltd 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Evogene Ltd ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.